|
CEP68 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.5436000496486E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.04710026707744E-10 |
| Normal-vs-Stage2 |
1.255770E-02 |
| Normal-vs-Stage3 |
3.144400E-02 |
| Normal-vs-Stage4 |
1.651570E-02 |
| Stage1-vs-Stage2 |
1.341040E-01 |
| Stage1-vs-Stage3 |
5.882300E-02 |
| Stage1-vs-Stage4 |
8.701600E-01 |
| Stage2-vs-Stage3 |
6.835000E-01 |
| Stage2-vs-Stage4 |
4.934400E-01 |
| Stage3-vs-Stage4 |
3.257200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.34849999950038E-08 |
| Normal-vs-AfricanAmerican |
3.09360004280279E-09 |
| Normal-vs-Asian |
1.015730E-02 |
| Caucasian-vs-AfricanAmerican |
1.372370E-01 |
| Caucasian-vs-Asian |
9.186000E-01 |
| AfricanAmerican-vs-Asian |
4.917400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.43949305200886E-12 |
| Normal-vs-Female |
1.411230E-01 |
| Male-vs-Female |
9.0088000004318E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.86232999999092E-05 |
| Normal-vs-Extreme_Weight |
1.0994000154696E-09 |
| Normal-vs-Obese |
4.10720000000309E-05 |
| Normal-vs-Extreme_Obese |
3.67540000001387E-06 |
| Normal_Weight-vs-Extreme_Weight |
2.132800E-01 |
| Normal_Weight-vs-Obese |
5.135000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.360600E-01 |
| Extreme_Weight-vs-Obese |
2.843600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.575600E-01 |
| Obese-vs-Extreme_Obese |
2.379400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.373800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.41449999952515E-07 |
| Normal-vs-Age(61-80Yrs) |
5.18849962993784E-10 |
| Normal-vs-Age(81-100Yrs) |
1.13840000004473E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.033200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.203600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.182100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.810000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.137800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.213200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.09179998375453E-09 |
| Normal-VS-Type2 PRCC |
3.06250003134778E-09 |
| Normal-VS-KIRP CIMP |
3.970000E-01 |
| Normal-VS-Unclassified PRCC |
1.107570E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.499400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.09770000003662E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
1.832180E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.23149999999795E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.746330E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.162180E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.77500014686416E-10 |
| Normal-vs-N1 |
2.072400E-01 |
| Normal-vs-N2 |
4.136000E-02 |
| N0-vs-N1 |
1.473610E-02 |
| N0-vs-N2 |
3.923200E-01 |
| N1-vs-N2 |
5.639600E-01 |
|
|
